ACXP Logo

Acurx Pharmaceuticals, Inc. (ACXP) 

NASDAQ
Market Cap
$14.87M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
513 of 963
Rank in Industry
275 of 552

Largest Insider Buys in Sector

ACXP Stock Price History Chart

ACXP Stock Performance

About Acurx Pharmaceuticals, Inc.

Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The company is also developing ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumoniae. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.

Insider Activity of Acurx Pharmaceuticals, Inc.

Over the last 12 months, insiders at Acurx Pharmaceuticals, Inc. have bought $0 and sold $0 worth of Acurx Pharmaceuticals, Inc. stock.

On average, over the past 5 years, insiders at Acurx Pharmaceuticals, Inc. have bought $149,611 and sold $0 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 5,161 shares for transaction amount of $24,979 was made by Sailer Carl (director) on 2021‑11‑23.

List of Insider Buy and Sell Transactions, Acurx Pharmaceuticals, Inc.

2021-11-23Purchasedirector
5,161
0.0628%
$4.84$24,979-21.67%
2021-11-19Purchase
5,034
0.0595%
$4.90$24,672-24.69%
2021-11-19PurchasePresident and CEO
5,200
0.0602%
$4.80$24,960-24.69%
2021-06-29Purchasedirector
12,500
0.1719%
$6.00$75,000-30.67%

Insider Historical Profitability

<0.0001%
DELUCCIA ROBERT J
1031461
6.106%
$0.8810<0.0001%
LUCI DAVID PPresident and CEO
1008723
5.9714%
$0.8810<0.0001%
Sailer Carldirector
73078
0.4326%
$0.8820<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
The Vanguard Group$1.2M3.1491,687+20.99%+$208,984.97<0.0001
Geode Capital Management$285,105.000.73116,352+3.76%+$10,340.55<0.0001
Advisor Group Holdings Inc$140,262.000.3657,2500%+$0<0.0001
State Street$106,492.000.2743,466+52.16%+$36,505.10<0.0001
LINSCO PRIVATE LEDGER CORP$98,576.000.2540,235+194.12%+$65,059.92<0.0001
Susquehanna International Group$91,723.000.2437,438-30.09%-$39,481.71<0.0001
Morgan Stanley$64,682.000.1726,401+62.96%+$24,989.83<0.0001
BlackRock$45,786.000.1218,688-70.4%-$108,874.05<0.0001
Northern Trust$42,025.000.1117,1530%+$0<0.0001
Group One Trading$33,028.000.0913,481New+$33,028.00<0.0001
Two Sigma$31,816.000.0812,986New+$31,816.00<0.0001
Xtx Topco Ltd$31,950.000.0813,041New+$31,950.00<0.01
Simplex Trading Llc$26,000.000.0710,729New+$26,000.00<0.01
Patriot Financial Group Insurance Agency Llc$25,443.000.0710,385New+$25,443.00<0.01
Tocqueville Asset Management$24,500.000.0610,000-23.66%-$7,595.00<0.0001
Cambridge Investment Research Advisors Inc$25,000.000.0610,000New+$25,000.00<0.0001
Semmax Financial Advisors Inc$12,287.000.045,8790%+$0<0.01
Cornerstone Planning Group Llc$7,257.000.023,3440%+$0<0.01
Tower Research Capital$7,027.000.022,868New+$7,027.00<0.0001
Cutler Group Lp$2,000.000.011,200-47.83%-$1,833.33<0.01
GPS Wealth Strategies Group LLC$1,225.00<0.015000%+$0<0.0001
Wells Fargo$213.00<0.0187+7.41%+$14.69<0.0001
Royal Bank of Canada$0<0.0137-30.19%-$0<0.0001
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.